Synthesis of structural analogues of leukotriene B4 and their receptor binding activity

Bioorganic and Medicinal Chemistry

Volumn 5, Issue 8, 1997, Pages 1621-1647

  Konno, Mitoshi ^a   Nakae, Takahiko ^a   Sakuyama, Shigeru ^a   Odagaki, Yoshihiko ^a   Nakai, Hisao ^a   Hamanaka, Nobuyuki ^a  

^a ONO PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR ANTAGONIST;

ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NEUTROPHIL; STRUCTURE ACTIVITY RELATION;

CELL AGGREGATION; HUMANS; LEUKOTRIENE B4; MODELS, MOLECULAR; NEUTROPHILS; RECEPTORS, LEUKOTRIENE B4;

EID: 0030819909     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(97)00090-4     Document Type: Article

References (23)

1. (a) Bray, M. A. Agents Actions 1986, 19, 87.
2. (b) Brain, S. D.; Williams, T. J. Pharmac. ther. 1990, 46, 57.
3. Thorsen, S.; Fogh, K.; Broby-Johansen, U.; Sondergaard, J. Allergy 1990, 45, 457.
4. Fretland, D. J.; Widomski, D. L.; Levin, S.; Gaginella, T. S. Inflammation 1990, 14, 143.
5. Klickstein, L. B.; Shapleigh, C; Goetzl, E. J. J. Clin. Invest.. 1980, 66, 1166.
6. Rae, S. A.; Davidson, E. M.; Smith, M. J. H. Lancet 1982, 1122.
7. Ford-Hutchinson, A. W. Crit. Rev. Immunol. 1990, 10, 1.
8. Yamamoto, H.; Furuta, K.; Ishiguro, M.; Haruta, R.; Ikeda, N. Bull. Chem. Soc. Jpn. 1984, 57, 2768.
9. The intramolecular cyclization of the amide ester chain of 18b was observed in this case. This difference from other similar examples may depend on slight differences in the reaction conditions such as reaction temperature, reaction time, and equivalent of sodium hydride, among others. This reaction was not optimized.
10. 5: C, 63.47; H, 7.99; N, 7.40%. Found: C, 63.00; H, 7.19; N, 7.44%.
11. 5: C, 64.07; H, 8.07; N, 4.15%. Found: C, 64.12; H, 7.79; N, 4.08%.
12. 5 337.18894).
13. Corey, E.J.; Bakshi, R. K. Tetrahedron Lett. 1990, 31, 611, and references therein.
14. Mosher, H. S.; Sullivan, G. R.; Dale, J. A. J. Org. Chem. 1973, 38, 2143, and references therein.
15. The synthetic method of compound 55 will be described in an accompanying paper. Konno, M.; Nakae, T.; Sakuyama, S.; Odagaki, Y.; Nakai, H.; Hamanaka, N. Bioorg. Med. Chem. 1997, 5, 1649.
16. (a) Kishikawa, K.; Tateishi, N.; Maruyama, R.; Seo, R.; Toda, M.; Miyamoto, T. Prostaglangins 1992, 44, 261-275.
17. (b) Kishikawa, K.; Nakao, S.; Matsumoto, S.; Kondo, K.; Hamanaka, N. In Advances in Prostaglandin, Thromboxane, and Leukotriene Reseach; Samuelsson, B. et al., Eds; Raven Press: New York, 1995; Vol. 23, pp 279-281.
18. Sugiura, M.; Beierbeck, H.; Belanger, P. C.; Kotovych, G. J. Am. Chem. Soc. 1984, 106, 4021.
19. LeBlanc, Y.; Fitzsimmons, B. J.; Charleston, S.; Alexander, P.; Evans. J. F.; Rokach, J. Prostaglandins 1987, 33, 617.
20. Namiki, M.; Iganashi, Y.; Sakamoto, K.; Koga, Y. Biochem. Biophys. Res. Commun. 1986, 138, 540.
21. Quanta/CHARMm, a molecular modeling system, is supplied by Molecular Simulations, 9685 Scranton Road, San Diego, CA 92121-3752, U.S.A.
22. Corey, E. J.; Marfat, A.; Goto, G.; Brion, F. J. Am. Chem. Soc. 1980, 102, 7984.
23. Gorman, R. R.; Lin, A. H. In Methods Enzymol.; Conn, P. M.; Means, A. R., Ed.; Academic Press: London, 1987; Vol 141, pp 372-378.